scholarly article | Q13442814 |
P50 | author | Tone F. Bathen | Q61104171 |
P2093 | author name string | Arend Heerschap | |
Tone F Bathen | |||
Tom Scheenen | |||
Mattijs Elschot | |||
Elise Sandsmark | |||
Helena Bertilsson | |||
Kirsten M Selnæs | |||
Nassim Tayari | |||
Morteza Esmaeili | |||
P2860 | cites work | Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy | Q87828465 |
18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients | Q89771987 | ||
Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans. | Q40227639 | ||
Simultaneous (68)Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. | Q40959799 | ||
Leucine and calcium regulate fat metabolism and energy partitioning in murine adipocytes and muscle cells | Q42829542 | ||
Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T. | Q46500550 | ||
Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score | Q46956034 | ||
A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer | Q48243611 | ||
Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience | Q48905216 | ||
Combined (18)F-Fluciclovine PET/MRI shows potential for detection and characterization of high-risk prostate cancer | Q49547411 | ||
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy | Q50260314 | ||
The clinical safety, biodistribution and internal radiation dosimetry of [¹⁸F]fluciclovine in healthy adult volunteers. | Q50491976 | ||
Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans. | Q51753150 | ||
Clinical PET Imaging in Prostate Cancer. | Q51809435 | ||
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI. | Q52940451 | ||
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial. | Q52984458 | ||
Global cancer statistics, 2012 | Q27860501 | ||
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 | Q29037908 | ||
Prostate Cancer Predictive Simulation Modelling, Assessing the Risk Technique (PCP-SMART): Introduction and Initial Clinical Efficacy Evaluation Data Presentation of a Simple Novel Mathematical Simulation Modelling Method, Devised to Predict the Out | Q31117716 | ||
Improved method for accurate and efficient quantification of MRS data with use of prior knowledge | Q32172320 | ||
Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection | Q33261888 | ||
Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease. | Q34451031 | ||
Leucine Modulates Mitochondrial Biogenesis and SIRT1-AMPK Signaling in C2C12 Myotubes | Q34454206 | ||
The role of leucine and its metabolites in protein and energy metabolism | Q34488824 | ||
Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis | Q34681143 | ||
Improved volume selective (1) H MR spectroscopic imaging of the prostate with gradient offset independent adiabaticity pulses at 3 tesla | Q35284153 | ||
High-Quality 3-Dimensional 1H Magnetic Resonance Spectroscopic Imaging of the Prostate Without Endorectal Receive Coil Using A Semi-LASER Sequence | Q36410307 | ||
Prostate MRSI predicts outcome in radical prostatectomy patients | Q36879999 | ||
Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines | Q36949507 | ||
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature. | Q37918311 | ||
Prostate cancer: multiparametric MR imaging for detection, localization, and staging. | Q37935483 | ||
Update on the Gleason grading system | Q37952882 | ||
Mapping of prostate cancer by 1H MRSI. | Q38114017 | ||
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. | Q38160994 | ||
Metabolite ratios in 1H MR spectroscopic imaging of the prostate | Q38184479 | ||
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives. | Q38479661 | ||
Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate. | Q38595176 | ||
In vivo MR spectroscopic imaging of the prostate, from application to interpretation | Q38975826 | ||
Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer | Q39508939 | ||
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma | Q40186415 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | positron emission tomography | Q208376 |
P304 | page(s) | 516 | |
P577 | publication date | 2018-11-15 | |
P1433 | published in | Frontiers in Oncology | Q26839986 |
P1476 | title | Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer | |
P478 | volume | 8 |
Search more.